Patents by Inventor Marc J. Gurwith

Marc J. Gurwith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DHEA composition and method
    Patent number: 7045513
    Abstract: Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.
    Type: Grant
    Filed: March 16, 2000
    Date of Patent: May 16, 2006
    Assignee: Genelabs Technologies, Inc.
    Inventors: Jagdish Parasrampuria, Maxine B. Yonker, Kenneth E. Schwartz, Marc J. Gurwith
  • Treatment of SLE with dehydroepiandrosterone
    Publication number: 20030181435
    Abstract: This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
    Type: Application
    Filed: January 8, 2003
    Publication date: September 25, 2003
    Applicant: Genelabs Technologies, Inc.
    Inventors: Kenneth E. Schwartz, Marc J. Gurwith
  • Treatment of SLE with dehydroepiandrosterone
    Patent number: 6552010
    Abstract: This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: April 22, 2003
    Assignee: Genelabs Technologies, Inc.
    Inventors: Kenneth E. Schwartz, Marc J. Gurwith